H.R.3980 - Human Fetal Tissue Reporting and Disclosure Act of 2000106th Congress (1999-2000)
|Sponsor:||Rep. Coburn, Tom [R-OK-2] (Introduced 03/15/2000)|
|Committees:||House - Commerce|
|Latest Action:||House - 03/27/2000 Referred to the Subcommittee on Health and Environment. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.3980 — 106th Congress (1999-2000)All Information (Except Text)
Human Fetal Tissue Reporting and Disclosure Act of 2000 - Amends the Public Health Service Act to require entities that are to receive fetal tissue for any purpose, other than solely for purpose of pathological examination, to file a disclosure statement with the Secretary of Health and Human Services that contains: (1) a list of each entity that has obtained possession of the tissue prior to possession by the filing entity; (2) a description of the use to be made of such tissue and the end user; (3) a verification that the tissue was obtained with the donor's legal consent; (4) a description of the type of tissue involved, including a determination of whether it was obtained from an induced abortion; (5) a description of the quantity of tissue involved; (6) a description of the money or any other consideration of value transferred as a result of the transference of the tissue; and (7) any other information determined appropriate by the Secretary.
Introduced in House (03/15/2000)
Directs entities that enter into contracts for shipment of packages containing such tissue to: (1) notify the shipping entity that the package contains such tissue; (2) label the packaging to indicate that it contains such tissue; (3) ensure that shipment is done in a manner acceptable for the transfer of biomedical material; and (4) ensure that a tracking number is provided for the package.
Prescribes monetary penalties for violations of this Act.